Delivery Order SPE2DB24D2205-SPE2DB25FDZMB
- Not listed
- The Defense Logistics Agency awarded a $2,107.38 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (20 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $1,981.11 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This firm fixed-price contract, which must be completed by July 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a $2,092.43 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This competitively awarded, firm fixed-price delivery order is set to be completed by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement typical of routine medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.72 to AmerisourceBergen Drug Corp for Amoxicillin-Clavulanate 875-125 mg tablets (100 count) on August 14, 2025, with a completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,333.19 firm fixed-price contract is for the supply of Amoxicillin-Clavulanate 1,000-62.5 mg tablets to support military healthcare programs. The contract has an ultimate completion date of December 12, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in 100-count bottles. The $1,206.01 firm fixed-price contract has an ultimate completion date of August 23, 2024. As a large pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of essential medical commodities to various government agencies and healthcare programs. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for amoxicillin-clavulanate suspension (400-57 mg/5 ml, 100 ml) under a firm fixed-price contract with a ceiling value of $1,170.97. The award, issued on September 19, 2025, is a non-set-aside competitive procurement with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,032.05 contract is for the delivery of 20-count blister packs of Amox-Clav 875-125 mg tablets. This delivery order falls under an existing $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as a single-award vehicle. The IDC serves as...
- This federal contract award is for the delivery of 4,558,364,911 units of Amoxicillin-Clavulanate 875-125 mg tablets in 100-count bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 7, 2022, with a ceiling value of $3,189.64 and a completion date of September 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 100 tablets of the prescription medication Amoxicillin-Clavulanate 875-125 mg. The $5,756.53 firm fixed price contract has an ultimate completion date of April 17, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including a significant Indefinite...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FDZMBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count) with a ceiling value of $1,838.12. This competitive delivery order utilizes firm fixed-price terms and is scheduled for completion by March 12, 2025. The contract does not carry a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement. Performance will be executed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems worldwide. The underlying IDC enables the company to fulfill critical pharmaceutical requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key vendor within the DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/11/25 |